Biological Materials and Bioinspired Designs

A special issue of Biomimetics (ISSN 2313-7673). This special issue belongs to the section "Biomimetics of Materials and Structures".

Deadline for manuscript submissions: closed (20 April 2025) | Viewed by 878

Special Issue Editor


E-Mail
Guest Editor
Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA
Interests: biomaterials; tissue engineering; 3D bioprinting; drug delivery devices
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Biomaterials refer to substances designed to interact with biological tissues or fluids, serving critical roles in therapeutic and diagnostic contexts. The discipline of biomaterial science is inherently multidisciplinary, integrating insights from material science, chemistry, biology, biophysics, biomechanics, pharmaceutical sciences, tissue engineering, and medicine to devise innovative strategies for the treatment, repair, or replacement of diseased tissues and organs.

These materials serve as the foundation for a wide array of biomedical and pharmaceutical applications, playing a critical role in drug delivery systems, ranging from drug-eluting contact lenses to advanced nanocarriers, and are essential in the field of tissue engineering. Recent advancements in this area have focused on enhancing the biomimetic characteristics of engineered tissue constructs and biomedical devices, facilitating more effective therapeutic outcomes.

This Special Issue on biological materials and bioinspired designs in Biomimetics entitled “Innovations in Biomimetic Materials and Biomedical Devices: Bridging Science and Application" seeks to compile original research articles and comprehensive reviews on the following topics:

  • Three-dimensional bioprinting of organs and tissue constructs;
  • Development of smart devices within the biomedical arena;
  • Innovations in drug delivery systems and routes of administration;
  • Four-dimensional bioprinting techniques for the fabrication of intelligent organs, tissues, and devices;
  • Application of nanotechnology in drug delivery systems;
  • Design of stimuli-responsive materials and novel chemistries in biomedical applications.

We encourage your contributions to this vital field of research.

Dr. Wissam Farhat
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomimetics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomaterials
  • tissue engineering
  • nanotechnology
  • 3D and 4D bioprinting
  • smart materials
  • biomimetics
  • drug delivery systems

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

36 pages, 1078 KiB  
Review
Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy
by Shu Zhang, Aiyue Zhang, Xunhao Qi, Zongtai Han, Luqi Song, Jiayu Zhou, Guanglin Wang, Ran Zhu and Jianguo Li
Biomimetics 2025, 10(6), 394; https://doi.org/10.3390/biomimetics10060394 - 11 Jun 2025
Viewed by 542
Abstract
This paper presents a comprehensive review of recent advancements in radionuclide-labeled biomaterials for cancer therapy, with a particular focus on the characteristics, production methods, and labeling techniques of α-particle, β-particle, and Auger electron-based radiotherapy. It explores innovative strategies for targeted delivery systems and [...] Read more.
This paper presents a comprehensive review of recent advancements in radionuclide-labeled biomaterials for cancer therapy, with a particular focus on the characteristics, production methods, and labeling techniques of α-particle, β-particle, and Auger electron-based radiotherapy. It explores innovative strategies for targeted delivery systems and highlights the advantages of theranostics and combination therapies. The application of radionuclide-labeled biomaterials in various cancer types, including prostate cancer, breast cancer, neuroendocrine tumors, gliomas, and melanoma, is systematically summarized. Furthermore, the article critically examines current technological bottlenecks and challenges in clinical translation, while proposing future directions such as AI-assisted dose optimization and multimodal combination therapies. This review provides essential theoretical foundations and practical insights to facilitate the clinical translation of radionuclide-labeled biomaterials. Full article
(This article belongs to the Special Issue Biological Materials and Bioinspired Designs)
Show Figures

Graphical abstract

Back to TopTop